# ESE Evolution Report Summary

## GlycoSMILES2BAP Experiment Pipeline - Cycle 2

**Date**: 2026-03-21
**Trigger**: Experiment pipeline completed successfully (all 4 stages passed)
**Evolution Type**: ESE (Experiment Strategy Evolution)

---

## Executive Summary

The GlycoSMILES2BAP project has completed a full experiment cycle including:
- Initial benchmark validation (n=50)
- Expanded benchmark validation (n=1000)
- Ablation study (n=20, 5 conditions)
- Paper manuscript update with all results

All stages passed success criteria, enabling ESE evolution.

---

## Strategies Extracted

### Data Processing Strategies (2)
1. **ABL-1**: Representative Subset Selection for Ablation
2. **ABL-2**: Multi-Metric Cross-Validation in Ablation

### Architecture Strategies (2)
3. **ABL-3**: Modular Pipeline Design for Independent Testing
4. **ABL-4**: Category-Aware Anomeric Position Tracking

### Debugging Strategies (1)
5. **ABL-5**: Module-Level Ablation for Diagnosis

---

## Ideation Memory Updates

### Direction Status Update

**"Structured notation canonicalization for glycan input fidelity in structure prediction"**

- Previous Status: `feasible`
- New Status: `✅ VALIDATED`
- Evidence Added: 
  - Full implementation achieves 97.8% epimer, 97.4% anomeric, 95.9% linkage accuracy on n=1000 benchmark
  - Ablation study confirms all modules essential
  - Paper manuscript updated with Table 3

---

## Files Modified

| File | Action | Content |
|------|--------|---------|
| `/memory/ideation-memory.md` | Updated | Direction status → VALIDATED |
| `/memory/experiment-memory.md` | Extended | Added 5 ESE strategies |
| `/memory/evolution-reports/cycle_2_ese_ablation_success.md` | Created | Full ESE report |

---

## Metrics Summary

### Full Pipeline Performance (n=1000)
| Metric | Value | 95% CI |
|--------|-------|--------|
| Epimer accuracy | 97.8% | [97.1%, 98.4%] |
| Anomeric accuracy | 97.4% | [96.6%, 98.1%] |
| Linkage accuracy | 95.9% | [94.8%, 96.9%] |

### Ablation Study (n=20)
| Module Removed | Primary Impact | Δ Accuracy |
|----------------|---------------|------------|
| CCD Mapper | Epimer | -15.5% |
| Anomeric Tracker | Anomeric | -18.9% |
| Branch Handler | Linkage | -13.5% |
| BAP Generator | Both | -47.4%/-45.9% |

---

## Impact on Future Cycles

### For Idea-Tournament
- The validated direction can seed new branches for extensions
- Proven architecture pattern (modular pipeline) can inform similar designs

### For Experiment-Pipeline
- ABL-1 through ABL-5 strategies available for retrieval
- Category-aware processing confirmed as best practice
- Multi-metric evaluation recommended for specialized modules

---

## Recommendations

1. **Archive successful strategies** - All 5 strategies are production-ready
2. **Update paper** - Submit manuscript with ablation results
3. **Plan extension** - Consider bacterial/plant glycan support
4. **Community release** - Open-source implementation ready for GitHub

---

**Report Generated**: 2026-03-21
**ESE Protocol Version**: 1.0